You might think that using an insecticides to kill bugs would be the most efficient and cost-effective way to control the spread of these pests.
But the reality is that, despite the best efforts of some countries, they have struggled to eradicate the spread.
And the lack of success in the fight against the world’s most deadly and ubiquitous pest has left the public and businesses struggling to keep up.
The answer, experts say, lies in the industrial disinfection of surfaces.
A report released in the journal Science by researchers from the US and Australia says that while disinfection techniques have changed significantly over the last 30 years, the basic principle is the same: chemicals such as DDT are the best way to kill the world, but there are many other methods that can be used.
What we know so far, says lead author Michael Burdon, is that many different chemicals have been used to kill insects, but some are still used.
One of the chemicals is pyrethroid acid, which is commonly used as a paint thinner.
It has a strong smell and can be found in a range of paints, including acrylic, lacquer, and clear coat.
Another is polychlorinated biphenyl, or PCB, which can be in plastics and rubber products as well as household cleaners.
And finally, there is the common insecticide boric acid.
In the report, Burdont and his colleagues examined the data on the use of disinfectants across different industries.
Using the information from these studies, the researchers concluded that most industries have not been using a complete range of disinfectant products and methods to effectively control the global spread of the world-wide scourge of the bug.
Burdon’s team also found that the methods used by countries are largely driven by national policy.
They argue that the need to control insects in the face of climate change and economic uncertainty makes it more urgent to get the chemicals out of the country before it becomes a new problem.
The study is published in the scientific journal Science Advances.
This article first appeared on MedNewsToday.
Follow Michael Buddon on Twitter.